Wester H A, Siegers C P
Int J Clin Pharmacol Ther Toxicol. 1980 Dec;18(12):513-7.
10 healthy volunteers were randomized in two groups and treated with mianserin and amitriptyline for 6 days. Heart rate, arterial blood pressure, and blood levels of the drugs were measured daily. ECG and left-ventricular echocardiogram as a parameter of contractility were registered before as well as after 3 and 6 days of treatment with both drugs. The most striking result of our investigation was that amitriptyline-treated subjects showed a loss of myocardial contractility (-17% of the initial value) after 6 days of treatment; mianserin was ineffective in this respect. After both mianserin and amitriptyline an increase of the mean arterial blood pressure was observed; an increased heart rate was seen only in the amitriptyline group. No alterations in the parameters calculated from the ECG registrations were found in either group. The inability of mianserin to decrease cardiac contractility in the therapeutic dose range may favor this tetracyclic antidepressant over the tricyclic compound amitriptyline, especially in patients with cardiac disease.
10名健康志愿者被随机分为两组,分别接受米安色林和阿米替林治疗6天。每天测量心率、动脉血压和药物血药浓度。在使用这两种药物治疗3天和6天之前及之后,记录心电图和作为收缩性参数的左心室超声心动图。我们研究最显著的结果是,接受阿米替林治疗的受试者在治疗6天后心肌收缩性下降(降至初始值的-17%);米安色林在这方面无效。使用米安色林和阿米替林后均观察到平均动脉血压升高;仅在阿米替林组观察到心率增加。两组中根据心电图记录计算的参数均未发现改变。米安色林在治疗剂量范围内无法降低心脏收缩性,这可能使这种四环类抗抑郁药比三环类化合物阿米替林更具优势,尤其是在患有心脏病的患者中。